Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors

NCT01138033 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline